B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Report

Global and China B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 22, 2022
  • PAGES：179
  • REPORT CODE：GMM1485388
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the B-Cell Maturation Antigen(BCMA) Targeted Therapies industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Juno Therapeutics

    • Onyx Pharmaceuticals

    • Sutro Biopharma

    • Dana-Farber Cancer Institute

    • firstVentury Equity

    • Eureka Therapeutics

    • Five Prime Therapeutics

    • Malin Corporation

    • Deerfield Partners

    • Transposagen Biopharmaceuticals

    • Credit Suisse Securities

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Bispecific Antibodies

    • Antibody Drug Conjugates

    • Chimeric Antigen Receptor T-Cells

    Application:

    • Liver Cancer

    • Respiratory Cancer

    • Brain Cancer

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry Overview

      • 1.1.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Scope and Market Segments

      • 1.1.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry Characteristics

      • 1.1.3 Global and China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Value and Growth Rate (2017-2028)

    • 1.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Bispecific Antibodies

      • 1.2.2 Antibody Drug Conjugates

      • 1.2.3 Chimeric Antigen Receptor T-Cells

    • 1.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Liver Cancer

      • 1.3.2 Respiratory Cancer

      • 1.3.3 Brain Cancer

      • 1.3.4 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry Porter's Five Forces Model Analysis

      • 2.2.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry PEST Analysis

    • 2.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry

    Chapter 3 Global and China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market, by Manufacturer

    • 3.1 Global and China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Top 3 Players

    Chapter 4 Global and China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market, by Type (2017-2028)

    • 4.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Trend, by Type

    • 4.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Price Trend, by Type (2017-2028)

    • 4.3 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Price Trend, by Type (2017-2028)

    Chapter 5 Global and China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis

    • 7.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market, by Type

    • 7.2 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market, by Application

    • 7.3 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis and Forecast, by Country

      • 7.3.1 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis

    • 8.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market, by Type

    • 8.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market, by Application

    • 8.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis and Forecast, by Country

      • 8.3.1 Germany B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis

    • 9.1 APAC B-Cell Maturation Antigen(BCMA) Targeted Therapies Market, by Type

    • 9.2 APAC B-Cell Maturation Antigen(BCMA) Targeted Therapies Market, by Application

    • 9.3 APAC B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis and Forecast, by Country

      • 9.3.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis

    • 10.1 Latin America, Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market, by Type

    • 10.2 Latin America, Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market, by Application

    • 10.3 Latin America, Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China B-Cell Maturation Antigen(BCMA) Targeted Therapies Company Profiles

      • 11.1 Juno Therapeutics

        • 11.1.1 Juno Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Profiles, Application and Specification

        • 11.1.3 Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Onyx Pharmaceuticals

        • 11.2.1 Onyx Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Profiles, Application and Specification

        • 11.2.3 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Sutro Biopharma

        • 11.3.1 Sutro Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Profiles, Application and Specification

        • 11.3.3 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Dana-Farber Cancer Institute

        • 11.4.1 Dana-Farber Cancer Institute Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Profiles, Application and Specification

        • 11.4.3 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 firstVentury Equity

        • 11.5.1 firstVentury Equity Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Profiles, Application and Specification

        • 11.5.3 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Eureka Therapeutics

        • 11.6.1 Eureka Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Profiles, Application and Specification

        • 11.6.3 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Five Prime Therapeutics

        • 11.7.1 Five Prime Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Profiles, Application and Specification

        • 11.7.3 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Malin Corporation

        • 11.8.1 Malin Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Profiles, Application and Specification

        • 11.8.3 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Deerfield Partners

        • 11.9.1 Deerfield Partners Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Profiles, Application and Specification

        • 11.9.3 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Transposagen Biopharmaceuticals

        • 11.10.1 Transposagen Biopharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Profiles, Application and Specification

        • 11.10.3 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Credit Suisse Securities

        • 11.11.1 Credit Suisse Securities Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Profiles, Application and Specification

        • 11.11.3 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry Investment Prospect and Risk Assessment

    • 12.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Value and Growth Rate (2017-2028)

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Value and Growth Rate (2017-2028)

    • Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Bispecific Antibodies (2017-2028)

    • Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Antibody Drug Conjugates (2017-2028)

    • Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Chimeric Antigen Receptor T-Cells (2017-2028)

    • Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Liver Cancer (2017-2028)

    • Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Respiratory Cancer (2017-2028)

    • Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Brain Cancer (2017-2028)

    • Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size and Growth Rate of Others (2017-2028)

    • Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value, by Manufacturer (2021&2022)

    • Table Global and China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share, by Manufacturer (2021&2022)

    • Figure Global and China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share, by Manufacturer in 2021

    • Figure Global and China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share, by Manufacturer in 2022

    • Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, by Type (2017-2028)

    • Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Type (2017-2028)

    • Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Type (2017-2028)

    • Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value, by Type (2017-2028)

    • Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value Share, by Type (2017-2028)

    • Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Price Trend, by Type (2017-2028)

    • Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, by Type (2017-2028)

    • Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Type (2017-2028)

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Type (2017-2028)

    • Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value, by Type (2017-2028)

    • Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value Share, by Type (2017-2028)

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Price Trend, by Type (2017-2028)

    • Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, by Application (2017-2028)

    • Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Application (2017-2028)

    • Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Application (2017-2028)

    • Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value, by Application (2017-2028)

    • Table Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value Share, by Application (2017-2028)

    • Figure Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value Share, by Application (2017-2028)

    • Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, by Application (2017-2028)

    • Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Application (2017-2028)

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Application (2017-2028)

    • Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value, by Application (2017-2028)

    • Table China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value Share, by Application (2017-2028)

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value Share, by Application (2017-2028)

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Import, Consumption and Export (2017-2022)

    • Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Import, Consumption and Export (2017-2022)

    • Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Import, Consumption and Export (2017-2022)

    • Figure APAC B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Import, Consumption and Export (2017-2022)

    • Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, by Type (2017-2028)

    • Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Type (2017-2028)

    • Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Type (2017-2028)

    • Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, by Application (2017-2028)

    • Table North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Application (2017-2028)

    • Figure North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Application (2017-2028)

    • Figure United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Canada B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Canada B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Mexico B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, by Type (2017-2028)

    • Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Type (2017-2028)

    • Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Type (2017-2028)

    • Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, by Application (2017-2028)

    • Table Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Application (2017-2028)

    • Figure Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Application (2017-2028)

    • Figure Germany B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Germany B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure UK B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure UK B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure France B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure France B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Italy B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Italy B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Spain B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Spain B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Belgium B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Poland B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Poland B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Russia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Russia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Turkey B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Table APAC B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, by Type (2017-2028)

    • Table APAC B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Type (2017-2028)

    • Figure APAC B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Type (2017-2028)

    • Table APAC B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, by Application (2017-2028)

    • Table APAC B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Application (2017-2028)

    • Figure APAC B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Application (2017-2028)

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure South Korea B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Brazil B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure South Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Argentina B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Value and Growth Rate (2017-2028)

    • Table Juno Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Juno Therapeutics Product Profiles, Application and Specification

    • Table Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Onyx Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Onyx Pharmaceuticals Product Profiles, Application and Specification

    • Table Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sutro Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sutro Biopharma Product Profiles, Application and Specification

    • Table Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Dana-Farber Cancer Institute Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Dana-Farber Cancer Institute Product Profiles, Application and Specification

    • Table Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table firstVentury Equity Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table firstVentury Equity Product Profiles, Application and Specification

    • Table firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eureka Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eureka Therapeutics Product Profiles, Application and Specification

    • Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Five Prime Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Five Prime Therapeutics Product Profiles, Application and Specification

    • Table Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Malin Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Malin Corporation Product Profiles, Application and Specification

    • Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Deerfield Partners Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Deerfield Partners Product Profiles, Application and Specification

    • Table Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Transposagen Biopharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Transposagen Biopharmaceuticals Product Profiles, Application and Specification

    • Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Credit Suisse Securities Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Credit Suisse Securities Product Profiles, Application and Specification

    • Table Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US